Allergan (United States)

Allergan (United States)

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Allergan (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

46%


Total
Publications

2.5K


Total Open
Publications

1.1K


Total
Citations

110K


Open Access
Percentage

46%


Total
Publications

2.5K


Total Open
Publications

1.1K


Total
Citations

110K

Wikipedia

Website

download

Breakdown

17% 23% 6% 54%

Publisher Open

17%

Both

23%

Other Platform Open

6%

Closed

54%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

32%OA Journal

OA Journal 32%

316

Hybrid 49%

493

No Guarantees 19%

193

Other Platform Open

Domain 91%

651

Public 15%

105

Institution 11%

81

Other Internet 9%

65

Preprint 1%

10

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
644
Europe PMC
Domain
383
Semantic Scholar
Public
99
Taylor and Francis Group - Dove Medical Press
Other Internet
42
California Digital Library - eScholarship
Other Internet
14
University of California - eScholarship University of California
Institution
10
University College London - UCL Discovery
Institution
7
University of Nottingham - Repository@Nottingham
Institution
6
Monash University - Monash University Research Portal
Institution
6
Figshare
Public
6
1 / 9

Data updated 7 April 2025

Share

Share

Share